Hershey Beats Expectations, Buoyed by Charging Higher Prices

Hershey beat first-quarter expectations, with organic revenue growth of 7.9% and adjusted EPS of $2.35, helped by higher prices and easing cocoa costs. However, the company kept its 2026 outlook unchanged, which pressured shares, and the stock fell 2% intraday. Management said consumer demand remained steady, saw only a mild impact from food-aid restrictions, and noted GLP-1 drugs have not reduced chocolate and candy purchases.

Analysis

The market is discounting the wrong part of this print: not the quarter itself, but the durability of pricing power once cocoa relief fully flows through the P&L. If input costs continue easing while shelf prices stay elevated for another 1-2 quarters, gross margin expansion could look mechanically strong, but that also raises the probability of volume elasticity reappearing with a lag as consumers eventually trade down or reset basket behavior. The key second-order effect is that Hershey may end up with better reported earnings before the market starts questioning whether the category is structurally over-earning.

Competitive dynamics matter more than headline beats. Smaller confectionery players and private label are the real beneficiaries of any demand softening because they can undercut on price while incumbents are stuck defending premium shelf space and promotional cadence; that typically shows up with a 1-2 quarter delay in scanner data. Meanwhile, gum and mint strength suggests GLP-1 users are shifting toward lower-calorie oral categories rather than exiting confectionery entirely, which is mildly negative for core chocolate mix but supportive for adjacent segments and for companies with broader mint/gum exposure.

The guidance restraint is the real tell: management is signaling that peak margin optimism is already in the tape. With cocoa futures off the highs, the stock has less fundamental support for multiple expansion, especially if investors were hoping for an easy 2026 re-rating. Tail risk is a renewed cocoa spike from geopolitics or West African supply disruption; that would re-open pricing leverage, but with a 3-6 month lag rather than immediately, making the next catalyst path asymmetric to the downside if prices normalize faster than consensus expects.

Key Decisions for Investors

• Short HSY vs long a defensive food basket over 1-3 months: fade the quality premium if cocoa keeps easing and the market starts pricing in margin normalization; target 5-8% relative underperformance with a tight stop on any cocoa supply shock.
• Sell near-dated HSY call spreads or buy put spreads into the next 4-8 weeks of scanner-data headlines: the risk/reward favors limited-premium downside exposure because the stock is vulnerable to multiple compression if guidance remains conservative.
• Long MDLZ / short HSY as a relative-value pair for 2-4 quarters: MDLZ has better category diversification and should be less exposed to a single-input margin unwind; expected spread widening if confectionery pricing power fades.
• Watch for a tactical long in cocoa-sensitive upstream names only on a renewed weather or geopolitics headline: the upside is better expressed in the commodity than in HSY equity because the stock now has more downside than upside from cost normalization.
• If food-aid restrictions broaden, use it as a short-term catalyst to fade HSY rallies rather than chase them; any policy-driven demand noise is likely to be transitory and less important than the coming margin reset.